Dataset Information


Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

ABSTRACT: A better understanding of human hepatocellular carcinoma (HCC) pathogenesis at the molecular level will facilitate the discovery of tumor-initiating events. Transcriptome sequencing revealed that adenosine-to-inosine (A?I) RNA editing of AZIN1 (encoding antizyme inhibitor 1) is increased in HCC specimens. A?I editing of AZIN1 transcripts, specifically regulated by ADAR1 (encoding adenosine deaminase acting on RNA-1), results in a serine-to-glycine substitution at residue 367 of AZIN1, located in ?-strand 15 (?15) and predicted to cause a conformational change, induced a cytoplasmic-to-nuclear translocation and conferred gain-of-function phenotypes that were manifested by augmented tumor-initiating potential and more aggressive behavior. Compared with wild-type AZIN1 protein, the edited form has a stronger affinity to antizyme, and the resultant higher AZIN1 protein stability promotes cell proliferation through the neutralization of antizyme-mediated degradation of ornithine decarboxylase (ODC) and cyclin D1 (CCND1). Collectively, A?I RNA editing of AZIN1 may be a potential driver in the pathogenesis of human cancers, particularly HCC.


PROVIDER: S-EPMC3783260 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6124399 | BioStudies
2018-01-01 | S-EPMC6299520 | BioStudies
2019-01-01 | S-EPMC6339593 | BioStudies
2011-01-01 | S-EPMC3760215 | BioStudies
2017-01-01 | S-EPMC5585977 | BioStudies
2014-01-01 | S-EPMC3995272 | BioStudies
2015-01-01 | S-EPMC4341880 | BioStudies
2016-01-01 | S-EPMC5035604 | BioStudies
2013-01-01 | S-EPMC3565035 | BioStudies
2015-01-01 | S-EPMC5444807 | BioStudies